Study Design
Cost-effectiveness analysis of a randomized plus observational cohort trial
Objective
Analyze cost-effectiveness of Spine Patient Outcomes Research Trial (SPORT) data over 4 years comparing surgery with non-operative care for three common diagnoses: spinal stenosis (SpS), degenerative spondylolisthesis (DS) and intervertebral disc herniation (IDH).
Summary of Background Data
Spine surgery rates continue to rise in the US, but the safety and economic value of these procedures remains uncertain.
Methods
Patients with image-confirmed diagnoses were followed in randomized or observational cohorts with data on resource use, productivity and EQ-5D health state values measured at 6 weeks, 3, 6, 12, 24, 36, and 48 months. For each diagnosis, cost per quality-adjusted life year (QALY) gained in 2004 US Dollars was estimated for surgery relative to non-operative care using a societal perspective, with costs and QALYs discounted at 3% per year.
Results
Surgery was performed initially or during the 4-year follow-up among 414/634 (65.3%) SPS, 391/601 (65.1%) DS and 789/1192 (66.2%) IDH patients. Surgery improved health, with persistent QALY differences observed through 4 years (SpS QALY gain 0.22; 95%CI: 0.15, 0.34; DS QALY gain 0.34, 95%CI: 0.30, 0.47; IDH QALY gain 0.34, 95%CI: 0.31, 0.38). Costs per QALY gained decreased for SPS from $77,600 at 2 years to $59,400 (95%CI: $37,059, $125,162) at 4 years; for DS from $115,600 to $64,300/QALY (95%CI: $32,864, $83,117); and for IDH from $34,355 to $20,600/QALY (95%CI: $4,539, $33,088).
Conclusions
Comparative effectiveness evidence for clearly defined diagnostic groups from SPORT shows good value for surgery compared with non-operative care over 4-years.